These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20719986)

  • 21. Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease.
    Hallander HO; Lepp T; Ljungman M; Netterlid E; Andersson M
    APMIS; 2010 Nov; 118(11):878-87. PubMed ID: 20955461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
    Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
    Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of Haemophilus influenzae type b disease in The Gambia 14 years after introduction of routine Haemophilus influenzae type b conjugate vaccine immunization.
    Oluwalana C; Howie SR; Secka O; Ideh RC; Ebruke B; Sambou S; Erskine J; Lowe Y; Corrah T; Adegbola RA
    J Pediatr; 2013 Jul; 163(1 Suppl):S4-7. PubMed ID: 23773593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response to Haemophilus influenzae type b conjugate vaccine in preterm infants.
    Tsuda K; Iwasaki S; Horiguchi H; Mori M; Nishimaki S; Seki K; Taguri M; Yokota S; Ishiwada N
    Pediatr Int; 2012 Feb; 54(1):64-7. PubMed ID: 22044495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.
    Goldblatt D; Vaz AR; Miller E
    J Infect Dis; 1998 Apr; 177(4):1112-5. PubMed ID: 9534995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
    Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
    Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease.
    Berthet F; Prehn A; Suter R; Ethevenaux C; Seger RA
    Pediatr Allergy Immunol; 1998 Aug; 9(3):156-60. PubMed ID: 9814731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity.
    Goldblatt D
    Arch Dis Child; 2008 Aug; 93(8):646-7. PubMed ID: 18644932
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of residency and urbanicity on Haemophilus influenzae Type b and pneumococcal immunization in Shanghai Children: a Retrospective Cohort Study.
    Wagner AL; Sun X; Montgomery JP; Huang Z; Boulton ML
    PLoS One; 2014; 9(5):e97800. PubMed ID: 24828814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
    Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
    Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.
    Ladhani S; Ramsay M; Flood J; Campbell H; Slack M; Pebody R; Findlow J; Newton E; Wilding M; Warrington R; Crawford H; Min S; Gray K; Martin S; Frankland S; Bokuvha N; Laher G; Borrow R
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines.
    Tejedor JC; Brzostek J; Konior R; Grunert D; Kolhe D; Baine Y; Van Der Wielen M
    Clin Vaccine Immunol; 2016 Jul; 23(7):555-63. PubMed ID: 27145999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.
    Kelly DF; Moxon ER; Yu LM; Pollard AJ
    Clin Vaccine Immunol; 2009 Feb; 16(2):246-52. PubMed ID: 18784340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
    Zarei AE; Redwan EM
    Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules.
    Hong E; Terrade A; Denizon M; Aouiti-Trabelsi M; Falguières M; Taha MK; Deghmane AE
    BMC Infect Dis; 2021 Jul; 21(1):715. PubMed ID: 34330228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries.
    Garcia S; Lagos R; Muñoz A; Picón T; Rosa R; Alfonso A; Abriata G; Gentile A; Romanin V; Regueira M; Chiavetta L; Agudelo CI; Castañeda E; De la Hoz F; Higuera AB; Arce P; Cohen AL; Verani J; Zuber P; Gabastou JM; Pastor D; Flannery B; Andrus J
    Vaccine; 2012 Jan; 30(2):486-92. PubMed ID: 22085550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
    Townsend K; Ladhani SN; Findlow H; Borrow R
    Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.